Company Merrimack Pharmaceuticals Inc Nasdaq
Equities
US5903281005
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 31/12/92 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 31/12/03 |
Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 31/12/03 |
Director/Board Member | 45 | 18/09/19 | |
Ulrik Nielsen
FOU | Founder | 52 | 31/12/92 |
Director/Board Member | 46 | 18/09/19 | |
Ana Radeljevic
BRD | Director/Board Member | 44 | 05/06/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,531,760 | 14,355,601 ( 98.79 %) | 0 | 98.79 % |
Company contact information
Merrimack Pharmaceuticals, Inc.
One Broadway 14th Floor
02142, Cambridge
+
http://www.merrimackpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |